Inhibition of 15‐hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke
MedComm · 2024-01 · 5 (1)
DOI: 10.1002/mco2.452 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 07.01.2024. Verfasst von Yunfei Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology School of Basic Medical Sciences Central South University Changsha Hunan China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke is an acute serious cerebrovascular disease with high mortality and disability. Ferroptosis is an important regulated cell death (RCD) in ischemic stroke. 15‐Hydroxyprostaglandin dehydrogenase (15‐PGDH), a degrading enzyme of prostaglandin E2 (PGE2), is shown to regulate RCD such as autophagy and apoptosis. The study aimed to determine whether 15‐PGDH regulates ferroptosis and ischemic stroke, and further the exact mechanism. We demonstrated that overexpression of 15‐PGDH in the brain tissues or primary cultured neurons significantly aggravated cerebral injury and neural ferroptosis in ischemic stroke. While inhibition of 15‐PGDH significantly protected against cerebral injury and neural ferroptosis, which benefits arise from the activation of the PGE2/PGE2 receptor 4 (EP4) axis. While the impact of 15‐PGDH was abolished with glutathione peroxidase 4 (GPX4) deficiency. Then, 15‐PGDH inhibitor was found to promote the activation of cAMP‐response element‐binding protein (CREB) and nuclear factor kappa‐B (NF‐κB) via the PGE2/EP4 axis, subsequently transcriptionally upregulate the expression of GPX4. In summary, our study indicates that inhibition of 15‐PGDH promotes the activation PGE2/EP4 axis, subsequently transcriptionally upregulates the expression of GPX4 via CREB and NF‐κB, and then protects neurons from ferroptosis and alleviates the ischemic stroke. Therefore, 15‐PGDH may be a potential therapeutic target for ischemic stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathophysiology School of Basic Medical Sciences Central South University Changsha Hunan China.
- Department of Neurosurgery Xiangya Hospital Central South University Changsha Hunan China.
- Sepsis Translational Medicine Key Lab of Hunan Province Changsha Hunan China.
- National Medicine Functional Experimental Teaching Center Central South University Changsha Hunan China.
- Postdoctoral Research Station of Biology School of Basic Medical Science Central South University Changsha Hunan China.
ORCID-Profile: Yunfei Xu
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, Y., Li, K., Zhao, Y., Zhou, L., He, N., Qiao, H., Xu, Q., Zhang, H., Liu, Y., & Zhao, J. (2024). Inhibition of 15‐hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke. MedComm, 5(1). https://doi.org/10.1002/mco2.452
Vancouver
Xu Y, Li K, Zhao Y, Zhou L, He N, Qiao H, et al. Inhibition of 15‐hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke. MedComm. 2024;5(1). doi:10.1002/mco2.452
BibTeX
@article{Xu2024,
author = {Xu, Yunfei and Li, Kexin and Zhao, Yao and Zhou, Lin and He, Nina and Qiao, Haoduo and Xu, Qing and Zhang, Huali and Liu, Ying and Zhao, Jie},
title = {Inhibition of 15‐hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke},
journal = {MedComm},
year = {2024},
volume = {5},
number = {1},
doi = {10.1002/mco2.452}
}
EUVIMED